A thyroid nodule biopsy is a quick, minimally invasive procedure that uses a thin needle to extract cells from a lump in your thyroid gland so they can be examined under a microscope for signs of cancer. The formal name is fine needle aspiration, or FNA. Most thyroid nodules turn out to be benign, but the biopsy is the most reliable way to tell the difference without surgery.
Why a Biopsy Gets Recommended
Not every thyroid nodule needs a biopsy. Doctors use an ultrasound scoring system to rate how suspicious a nodule looks based on features like tiny calcium deposits, an irregular shape, or a nodule that’s taller than it is wide. The score, combined with the nodule’s size, determines whether sampling is warranted.
Nodules that look mildly suspicious on ultrasound typically aren’t biopsied unless they’re at least 2.5 centimeters. Moderately suspicious nodules meet the threshold at 1.5 centimeters, and highly suspicious ones at just 1 centimeter. Smaller nodules below these cutoffs are usually monitored with follow-up ultrasounds rather than biopsied right away. Your doctor may also recommend a biopsy if a nodule is growing quickly or if you have risk factors like a family history of thyroid cancer or prior radiation exposure to the neck.
How the Procedure Works
You lie on your back with your neck slightly extended, often with a pillow behind your shoulders. A technician or doctor applies gel to your neck and places an ultrasound probe over the nodule to get a real-time image on a screen. After cleaning the skin, the doctor inserts a very thin needle (roughly the width of a standard blood draw needle or thinner) through the skin and into the nodule. You’ll be asked to stay still and not speak or swallow while the needle is in place.
Once inside the nodule, the needle is moved back and forth several times to collect cells. Some doctors apply gentle suction through an attached syringe, while others rely on the natural capillary action of the needle to draw cells in. The needle is then withdrawn and the cells are placed on a glass slide. This sampling is typically repeated two to four times, targeting different areas of the nodule, to make sure the pathologist has enough material to work with. If the nodule contains fluid, that fluid can be drained during the same procedure.
The entire process generally takes about 20 to 30 minutes from start to finish, though the actual needle sampling portion is considerably shorter. Some doctors use a small amount of local anesthetic to numb the skin beforehand, though many patients find the procedure tolerable without it.
Why Ultrasound Guidance Matters
Nearly all thyroid biopsies today are performed with ultrasound guidance rather than by feel alone. The difference in quality is significant. When doctors guide the needle by touch, roughly 27% of samples come back with too few cells to analyze. With ultrasound guidance, that rate drops to about 13%. For nodules smaller than 2 centimeters, ultrasound guidance is especially important because the needle is far more likely to land in the right spot. A large study of nearly 10,000 patients found that ultrasound-guided biopsies had a sensitivity of 97% compared to 92% for biopsies done by feel.
What to Do Before Your Biopsy
Preparation is straightforward. You don’t need to fast, and most people can eat and drink normally beforehand. The main thing to discuss with your doctor is whether you take blood thinners or anti-inflammatory medications like aspirin or ibuprofen, since these can increase bleeding risk. Your doctor will let you know if and when to pause these medications before the procedure.
Recovery and Side Effects
You can go home shortly after the biopsy and return to most normal activities the same day. The most common side effect is soreness at the needle site, which occurs in the vast majority of patients and typically resolves within a day or two. Minor bleeding or bruising at the site happens in roughly 3% to 26% of cases, depending on the nodule and how many passes were needed.
Serious complications are rare. Significant bleeding, infection, and breathing difficulty from swelling have been reported but are uncommon, and most can be managed if they occur. A small bandage over the puncture site is all that’s needed afterward.
How Results Are Classified
Pathologists classify thyroid biopsy results using a standardized six-category system called the Bethesda System. Each category carries a different estimated risk of cancer, which guides what happens next.
- Nondiagnostic: The sample didn’t contain enough cells to make a call. This happens in roughly 5% to 15% of biopsies and usually means the procedure needs to be repeated.
- Benign: The cells look normal. This is the most common result, and in most cases, the nodule is simply monitored over time.
- Atypia of undetermined significance: Some cells look slightly unusual but not clearly abnormal. The cancer risk is low but not negligible.
- Follicular neoplasm: The cell pattern suggests a type of growth that can be benign or cancerous, but the distinction can’t be made from a needle sample alone.
- Suspicious for malignancy: The cells have features that strongly suggest cancer, though a definitive diagnosis requires surgical removal.
- Malignant: Cancer cells are clearly present.
Most people receive their results within about one week.
What Happens With Unclear Results
About 15% to 30% of thyroid biopsies fall into one of the indeterminate categories, meaning the cells aren’t clearly benign or clearly cancerous. In the past, the main option for these patients was diagnostic surgery to remove part or all of the thyroid so the tissue could be examined more thoroughly.
Today, molecular testing offers an alternative. If your biopsy is indeterminate, your doctor may send the sample for a specialized genetic analysis that looks for mutations and gene expression patterns associated with thyroid cancer. These tests can help reclassify an indeterminate nodule as likely benign or likely cancerous. When a molecular test flags a nodule as suspicious, the likelihood of cancer at surgery is high, with one study finding cancer confirmed in about 86% of those cases. When the test suggests the nodule is benign, many patients can safely avoid surgery and continue with monitoring instead.
How Accurate Is the Biopsy Overall
A large meta-analysis covering more than 16,500 patients found that fine needle biopsy has an overall sensitivity of about 87% and a specificity of about 73% for detecting thyroid cancer. In practical terms, sensitivity means the biopsy catches roughly 87 out of 100 cancers. Specificity means that about 73 out of 100 benign nodules are correctly identified as noncancerous. The gap in specificity is partly because indeterminate results get lumped in, and those nodules often turn out to be benign after surgery.
No single test is perfect, which is why doctors combine biopsy results with ultrasound features, molecular testing when appropriate, and clinical judgment to decide on next steps. But for a procedure that takes under half an hour and involves minimal discomfort, fine needle aspiration remains the most effective first step for evaluating whether a thyroid nodule needs treatment.